Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Breast Neoplasms 1

Interventions

Temozolomide 16 Radiotherapy 7 apatinib 5 anlotinib 3 Surgical Procedures, Operative 3 Chlorotoxin 3 Bevacizumab 3 Aminolevulinic Acid 3 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Lomustine 2 Irinotecan 2 Immunotherapy, Adoptive 2 Blood Specimen Collection 2 vandetanib 1 sodium thiosulfate 1 ribociclib 1 poly ICLC 1 lonafarnib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 etoposide phosphate 1 Vinblastine 1 Valproic Acid 1 Tranexamic Acid 1 Surveys and Questionnaires 1 Sunitinib 1 Rivaroxaban 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioma × 68Ga-NOTA-RM26 × Clear all

NCT06412952 2024-05-14

68Ga-NOTA-RM26 PET/CT in Glioma Patients

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡